Bioinformatics Methodologies to Identify Interactions Between Type 2 Diabetes and Neurological Comorbidities

Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by high blood sugar and insulin insensitivity which greatly increases the risk of developing neurological diseases (NDs). The co-existence of T2D and comorbidities such as NDs can complicate or even cause the failure of standard treatments for those diseases. Comorbidities can be both causally linked and influence each other’s development through genetic, molecular, environmental or lifestyle-based risk factors that they share. For T2D and NDs, such underlying common molecular mechanisms remain elusive but large amounts of molecular data accumulated on these diseases enable analytical approaches to identify their interconnected pathways. Here, we propose a framework to explore possible comorbidity interactions between a pair of diseases using a bioinformatic examination of the cellular pathways involved and explore this framework for T2D and NDs with analyses of a large number of publicly available gene expression datasets from tissues affected by these diseases. We designed a bioinformatics pipeline to analyse, utilize and combine gene expression, Gene Ontology (GO) and molecular pathway data by incorporating Gene Set Enrichment Analysis and Semantic Similarity. Our bioinformatics methodology was implemented in R, available at https://github.com/HabibUCAS/T2D_Comorbidity. We identified genes with altered expression shared by T2D and NDs as well as GOs and molecular pathways these diseases share. We also computed the proximity between T2D and neurological pathologies using these genes and GO term semantic similarity. Thus, our method has generated new insights into disease mechanisms important for both T2D and NDs that may mediate their interaction. Our bioinformatics pipeline could be applied to other co-morbidities to identify possible interactions and causal relationships between them.

[1]  S. Bonner-Weir,et al.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. , 1983, The Journal of clinical investigation.

[2]  J. Leahy,et al.  Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions. , 1986, The Journal of clinical investigation.

[3]  R. DeFronzo,et al.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.

[4]  Yii-Der I. Chen,et al.  Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.

[5]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[6]  K. Walker,et al.  Body fat distribution and non-insulin-dependent diabetes: comparison of a fiber-rich, high-carbohydrate, low-fat (23%) diet and a 35% fat diet high in monounsaturated fat. , 1996, The American journal of clinical nutrition.

[7]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.

[8]  E. Cerasi,et al.  Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. , 1999, Diabetes.

[9]  K. Maedler,et al.  Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. , 2001, Diabetes.

[10]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[11]  D. Ron,et al.  Endoplasmic reticulum stress and the development of diabetes: a review. , 2002, Diabetes.

[12]  P. Halban,et al.  Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. , 2003, Diabetes.

[13]  M. Donath,et al.  Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. , 2003, Diabetes.

[14]  I. Goldfine,et al.  Are Oxidative StressActivated Signaling Pathways Mediators of Insulin Resistance and -Cell , 2003 .

[15]  Joseph L Evans,et al.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? , 2003, Diabetes.

[16]  Masataka Mori,et al.  Endoplasmic reticulum stress and diabetes mellitus. , 2003, Internal medicine.

[17]  G. Stephanopoulos,et al.  Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. , 2004, Physiological genomics.

[18]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Bonner-Weir,et al.  Five Stages of Evolving-Cell Dysfunction During Progression to Diabetes , 2004 .

[20]  R V Jensen,et al.  Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Sebastiano Cavallaro,et al.  Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis , 2007, BMC Genomics.

[23]  D. Maraganore,et al.  A Genomic Pathway Approach to a Complex Disease: Axon Guidance and Parkinson Disease , 2007, PLoS genetics.

[24]  Philip S. Yu,et al.  A new method to measure the semantic similarity of GO terms , 2007, Bioinform..

[25]  Sean R. Davis,et al.  GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..

[26]  R. Robertson,et al.  Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .

[27]  V. Kostic,et al.  Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion. , 2008, Archives of neurology.

[28]  Catia Pesquita,et al.  Metrics for GO based protein semantic similarity: a systematic evaluation , 2008, BMC Bioinformatics.

[29]  Lucas R. Smith,et al.  Novel transcriptional profile in wrist muscles from cerebral palsy patients , 2009, BMC Medical Genomics.

[30]  O. Maes,et al.  Methodology for discovery of Alzheimer's disease blood-based biomarkers. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  Albert-László Barabási,et al.  A Dynamic Network Approach for the Study of Human Phenotypes , 2009, PLoS Comput. Biol..

[32]  B. Spann,et al.  Transcriptome Analysis of Synaptoneurosomes Identifies Neuroplasticity Genes Overexpressed in Incipient Alzheimer's Disease , 2009, PloS one.

[33]  L. Mucke,et al.  Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.

[34]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[35]  Yibo Wu,et al.  GOSemSim: an R package for measuring semantic similarity among GO terms and gene products , 2010, Bioinform..

[36]  G. Petsko,et al.  Polyamine pathway contributes to the pathogenesis of Parkinson disease , 2010, Proceedings of the National Academy of Sciences.

[37]  Lorella Marselli,et al.  1 CLASS II PHOSPHOINOSITIDE 3-KINASE REGULATES EXOCYTOSIS OF INSULIN GRANULES IN PANCREATIC BETA CELLS , 2010 .

[38]  Dennis C. Sgroi,et al.  Gene Expression Profiles of Beta-Cell Enriched Tissue Obtained by Laser Capture Microdissection from Subjects with Type 2 Diabetes , 2010, PloS one.

[39]  Manuel B. Graeber,et al.  PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease , 2010, Science Translational Medicine.

[40]  Paul G. Ince,et al.  Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS) , 2010, PloS one.

[41]  R. L. Hull,et al.  Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? , 2010, Diabetologia.

[42]  R. Kofler,et al.  Expression, regulation and function of phosphofructo-kinase/fructose-biphosphatases (PFKFBs) in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia cells , 2010, BMC Cancer.

[43]  M. Honda,et al.  A liver-derived secretory protein, selenoprotein P, causes insulin resistance. , 2010, Cell metabolism.

[44]  Anjana Munshi,et al.  Genes associated with Alzheimer Disease , 2010 .

[45]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[46]  Mario Inostroza-Ponta,et al.  A Transcription Factor Map as Revealed by a Genome-Wide Gene Expression Analysis of Whole-Blood mRNA Transcriptome in Multiple Sclerosis , 2010, PloS one.

[47]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[48]  Panos N. Papapanou,et al.  Diabetes mellitus and periodontitis: a tale of two common interrelated diseases , 2011, Nature Reviews Endocrinology.

[49]  R. Mechelli,et al.  CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis. , 2011, Brain : a journal of neurology.

[50]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[51]  H. D. Rosas,et al.  Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse , 2011, Proceedings of the National Academy of Sciences.

[52]  T. Gasser,et al.  The Application of Clinical Genetics Dovepress Genetic Basis of Parkinson's Disease: Inheritance, Penetrance, and Expression , 2022 .

[53]  Eric M. Blalock,et al.  Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease , 2011, Journal of Chemical Neuroanatomy.

[54]  J. Kaprio,et al.  Systematic review of genome-wide expression studies in multiple sclerosis , 2011, BMJ Open.

[55]  S. Baranzini Revealing the genetic basis of multiple sclerosis: are we there yet? , 2011, Current opinion in genetics & development.

[56]  L. Defebvre,et al.  Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation , 2011, Neurobiology of Aging.

[57]  S. Greenberg,et al.  Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells , 2012, Journal of Neuroimmunology.

[58]  J. Epplen,et al.  Genetic modifiers of Huntington’s disease: beyond CAG , 2012 .

[59]  Lucas R. Smith,et al.  Transcriptional Abnormalities of Hamstring Muscle Contractures in Children with Cerebral Palsy , 2012, PloS one.

[60]  Tanya Barrett,et al.  Strategies to explore functional genomics data sets in NCBI's GEO database. , 2012, Methods in molecular biology.

[61]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[62]  M. Kubo,et al.  Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis , 2012, The Journal of Immunology.

[63]  W. Le,et al.  Genetics of amyotrophic lateral sclerosis: an update , 2013, Molecular Neurodegeneration.

[64]  Yvonne W. Cheng,et al.  Maternal diagnosis of obesity and risk of cerebral palsy in the child. , 2013, The Journal of pediatrics.

[65]  Charles Wang,et al.  Transcriptomic Profiling of Human Peritumoral Neocortex Tissues Revealed Genes Possibly Involved in Tumor-Induced Epilepsy , 2013, PloS one.

[66]  Sandeep Kumar Mathur,et al.  Systems Biology Approach Reveals Genome to Phenome Correlation in Type 2 Diabetes , 2013, PloS one.

[67]  Omar Ali,et al.  Genetics of type 2 diabetes. , 2013, World journal of diabetes.

[68]  Pietro Lio',et al.  Comorbidity: a multidimensional approach. , 2013, Trends in molecular medicine.

[69]  A. Kong,et al.  Diabetes and its comorbidities—where East meets West , 2013, Nature Reviews Endocrinology.

[70]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics* , 2013, Molecular & Cellular Proteomics.

[71]  R. Reynolds,et al.  Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions , 2014, Glia.

[72]  S. Limborska,et al.  Involvement of Endocytosis and Alternative Splicing in the Formation of the Pathological Process in the Early Stages of Parkinson's Disease , 2014, BioMed research international.

[73]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.

[74]  M. Farrer,et al.  Genetics and genomics of Parkinson’s disease , 2014, Genome Medicine.

[75]  Pietro Liò,et al.  comoR: a software for disease comorbidity risk assessment , 2014, Journal of Clinical Bioinformatics.

[76]  N. Pochet,et al.  Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 mice , 2015, Annals of neurology.

[77]  A. Oliveira,et al.  Clinical and genetic basis of familial amyotrophic lateral sclerosis. , 2015, Arquivos de neuro-psiquiatria.

[78]  C. Mungall,et al.  Gene Ontology Consortium : going forward The Gene Ontology , 2015 .

[79]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[80]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[81]  W. Robberecht,et al.  The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs , 2015 .

[82]  W. Ye,et al.  Association between diabetes and amyotrophic lateral sclerosis in Sweden , 2015, European journal of neurology.

[83]  M. Rattray,et al.  C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis , 2015, PloS one.

[84]  H. Mefford,et al.  Advancing epilepsy genetics in the genomic era , 2015, Genome Medicine.

[85]  Pietro Liò,et al.  CytoCom: a Cytoscape app to visualize, query and analyse disease comorbidity networks , 2015, Bioinform..

[86]  P. De Meyts,et al.  p38 MAPK activation upregulates proinflammatory pathways in skeletal muscle cells from insulin-resistant type 2 diabetic patients. , 2015, American journal of physiology. Endocrinology and metabolism.

[87]  P. Lio’,et al.  How to build personalized multi-omics comorbidity profiles , 2015, Front. Cell Dev. Biol..

[88]  S. Illarioshkin,et al.  Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons , 2016, Molecular Neurodegeneration.

[89]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[90]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[91]  J. Gécz,et al.  The genetic basis of cerebral palsy , 2017, Developmental medicine and child neurology.

[92]  Andrew Steptoe,et al.  Type 2 diabetes mellitus and psychological stress — a modifiable risk factor , 2017, Nature Reviews Endocrinology.

[93]  M. Schachner,et al.  Homophilic binding of the neural cell adhesion molecule CHL1 regulates development of ventral midbrain dopaminergic pathways , 2017, Scientific Reports.

[94]  M. Keske,et al.  A New Method for Targeted and Sustained Induction of Type 2 Diabetes in Rodents , 2017, Scientific Reports.

[95]  V. Mohan,et al.  Prevalence of type 2 diabetes and its complications in India and economic costs to the nation , 2017, European Journal of Clinical Nutrition.

[96]  Chung-Yi Li,et al.  A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus , 2017, Journal of epidemiology.

[97]  Simon Hametner,et al.  Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis , 2017, Brain : a journal of neurology.

[98]  Mohammad Ali Moni,et al.  Network-based identification of genetic factors in Ageing, lifestyle and Type 2 Diabetes that Influence in the progression of Alzheimer’s disease , 2018 .

[99]  Md. Rezanur Rahman,et al.  Common molecular biomarker signatures in blood and brain of Alzheimer’s disease , 2018, bioRxiv.

[100]  Mohammad Ali Moni,et al.  Genetic effect of Type 2 diabetes to the progression of neurological diseases , 2018 .

[101]  Laura Inés Furlong,et al.  comoRbidity: an R package for the systematic analysis of disease comorbidities , 2018, Bioinform..

[102]  B. Ritz,et al.  Type 2 Diabetes Mellitus and Alzheimer’s Disease: Overlapping Biologic Mechanisms and Environmental Risk Factors , 2018, Current Environmental Health Reports.

[103]  R. Jockers,et al.  Melatonin in type 2 diabetes mellitus and obesity , 2018, Nature Reviews Endocrinology.

[104]  John Hardy,et al.  The genetic landscape of Alzheimer disease. , 2018, Handbook of clinical neurology.

[105]  Mohammad Ali Moni,et al.  A System Biology Approach to Identify the Genetic Markers to the progression of Parkinson's disease for Aging, lifestyle and Type 2 Diabetes , 2018 .

[106]  Mohammad Ali Moni,et al.  Detection of multiple sclerosis using blood and brain cells transcript profiles: Insights from comprehensive bioinformatics approach , 2019, Informatics in Medicine Unlocked.

[107]  Mohammad Ali Moni,et al.  A computational approach to identify blood cell-expressed Parkinson's disease biomarkers that are coordinately expressed in brain tissue , 2019, Comput. Biol. Medicine.

[108]  Laura I. Furlong,et al.  Comorbidity4j: a tool for interactive analysis of disease comorbidities over large patient datasets , 2019, Bioinform..

[109]  Pietro Liò,et al.  Genetic Effects of Welding Fumes on the progression of Neurodegenerative Diseases , 2018, bioRxiv.

[110]  Mohammad Ali Moni,et al.  Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease , 2019, Comput. Biol. Chem..

[111]  Julian M. W. Quinn,et al.  Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective. , 2020, Genomics.

[112]  Mohammad Ali Moni,et al.  Discovering Biomarkers and Pathways Shared by Alzheimer’s Disease and Ischemic Stroke to Identify Novel Therapeutic Targets , 2019, Medicina.

[113]  Mohammad Ali Moni,et al.  Identification of molecular signatures and pathways common to blood cells and brain tissue of amyotrophic lateral sclerosis patients , 2019, Informatics in Medicine Unlocked.

[114]  Julian M. W. Quinn,et al.  Network‐based computational approach to identify genetic links between cardiomyopathy and its risk factors , 2020, IET systems biology.